Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prion diseases are fatal neurodegenerative diseases that affect humans and animals. Prion strains, conformational variants of misfolded prion proteins, are associated with distinct clinical and pathological phenotypes. Host-strain interactions result in the selective damage of distinct brain areas and they are responsible for strain selection and/or adaptation, but the underlying molecular mechanisms are unknown. Prion strains can be distinguished by their cell tropism
in vivo
and
in vitro
, which suggests that susceptibility to distinct prion strains is determined by cellular factors. The
neuroblastoma
cell line PK1 is refractory to the prion strain Me7, but highly susceptible to RML. We challenged a large number of clonal PK1 lines with Me7 and successfully selected highly Me7-susceptible subclones (
PME
) to investigate whether the prion strain repertoire of PK1 can be expanded. Notably, the Me7-infected
PME
clones were more protease-resistant when compared to RML-infected
PME
clones, which suggested that cell-adapted Me7 and RML are distinct prion strains. Strikingly, Me7-refractory cells, including PK1 and astrocytes in cortico-hippocampal cultures, are highly susceptible to prions, being derived from homogenates of Me7-infected
PME
cells, suggesting that the passage of Me7 in
PME
cells leads to an extended host range. Thus,
PME
clones represent a compelling cell model for strain selection and adaptation.
...
PMID:A New Cell Model for Investigating Prion Strain Selection and Adaptation. 3154 23